Newsroom Article Archive
As dozens of UT Southwestern nurses gathered to return to Dallas after serving patients at MD Anderson Cancer Center for two weeks following the floods from Hurricane Harvey, the tears were flowing.
A protein that helps break down lipids in the cell’s lysosome may be a key target for identifying and treating neurodegenerative diseases, according to a study by the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center.
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern researchers more than $34 million for cancer research and faculty recruitment, including support for programs in pancreatic cancer, lung cancer, breast cancer, and melanoma.
A national clinical trial at UT Southwestern Medical Center will test the best methods to encourage people to drink water to reduce the recurrence of kidney stones.
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology’s 2017 Congress in Spain.